ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer

On March 24, 2026, Barclays raised the terms people connected ABIVAX Société Anonyme (NASDAQ:ABVX) to $148 from $142 and maintained an Overweight rating. Barclays said a “clean” Data and Safety Monitoring Board reappraisal supports continued ABTECT maintenance, with a readout expected successful precocious Q2.

Photo by RephiLe h2o connected Unsplash

On March 15, 2026, Jefferies initiated sum connected ABIVAX Société Anonyme (NASDAQ:ABVX) with a Buy standing and a $160 terms target. Jefferies described obefazimod arsenic a “differentiated” attraction for ulcerative colitis and said the upcoming Q2 attraction readout appears “fairly de-risked,” portion besides pointing to imaginable successful Crohn’s disease.

ABIVAX Société Anonyme (NASDAQ:ABVX) develops therapeutics targeting chronic inflammatory diseases.

While we admit the imaginable of ABVX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.